CCI clears deal involving Sekhmet Pharmaventures and Optimus Drugs
Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CCI
CCI approves Serum Institute Life Sciences-Biocon Biologics deal
Once the deal is complete, Serum Institute Life Sciences will have about 15 per cent stake in Biocon Biologics, according to the…
CCI approves acquisition of Micro Life Sciences by South Elm Investments BV
The proposed combination pertains to the proposed acquisition of minority stake in Micro Life Sciences (Micro Life/Target) by…
National digital drugs databank will help address ‘information asymmetry’ in pharma space: CCI study
The fair trade watchdog, which works on ways to foster competition and curb anti-competitive practices, in the market study found…
Pharma sector study will identify steps to boost competition and ensure drug affordability: CCI…
Gupta said CCI is close to completing its study on the country’s pharmaceutical sector that is likely to be concluded within a…
CCI dismisses unfair business practices complaint against DGAFMS, ECHS Khanpur, eight pharma traders
Anant Pharmaceuticals, Saransh Biotech, Aarav Pharmaceuticals, Laxmi Pharma, M C Pharma, Maa Ambey Enterprises, Goyal Pharma and…
Cipla gets CCI nod to sell stake in consumer healthcare business
In November last year, the company signed an agreement to sell 26.11 per cent in Cipla Health to FIL Capital Investments…